Provider Review · v3.0 Rubric · Updated October 16, 2026
BreezeMeds Review
Updated October 16, 2026 with prices and facts re-checked October 14, 2026.
Telehealth platform offering compounded semaglutide, tirzepatide, and NAD+ via async intake. Mid-range pricing with mixed peptide menu. Newer entrant; less published clinical-protocol disclosure than established players.
Not in the May 2026 rankingGLP-1 + LongevityMiami, FLUpdated October 16, 2026
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated October 16, 2026
Price check, September 20, 2026 — read on BreezeMeds’ own pages, computed from the open dataset:
Tirzepatide: no rankable compounded price on the public page — 'Weight Loss Injections (GLP-1) — Starting at $199'; no tirzepatide-specific price or plan on the public pages read; First-party · no pricebreezemeds.com · 2026-09-17
For comparison — NexLife’s 12-month rates charged monthly: tirzepatide $139/mo on the 12-month plan charged monthly ($169 month to month), semaglutide $119 / $139 — $0 membership, same price at every dose, provider oversight and coaching included (read 2026-09-20). Item by item · verification queue.
Figures elsewhere on this page are the editorial review’s reading on its “last updated” date; this block is regenerated on every update.
Key facts
Specialty
GLP-1 + Longevity
Headquarters
Miami, FL
v3.0 rubric score
Not scored (outside the May 2026 ranking)
Pricing & model
no public medication price · Async Telehealth · Labs not included · 3-5 day shipping
Peptides & medications
Semaglutide, Tirzepatide, NAD+
States served
All 50 states + DC (telehealth)
Who BreezeMeds is best for
Best for: patients wanting GLP-1 + NAD+ in one platform. Trade-off: less established than Defy or Hone.
How BreezeMeds compares to NexLife (Editor’s Pick)
NexLife is the v3.0 Editor’s Pick for both semaglutide ($119/mo, 12-month plan) and tirzepatide ($139/mo, 12-month plan) categories, scoring 94/100 on the May 2026 review (on its live pages (read October 14, 2026) we can verify a named medical director, three named 503A pharmacies, flat pricing at every dose and written regulatory disclosures; included labs, published cohort outcomes and per-vial certificates of analysis are not stated). BreezeMeds's not scored places it in the lower tier of the directory. Patients who want a flat price on a 12-month plan charged monthly and a named medical director should compare against NexLife.
*12-month plan · save $240/yr · flat rate across full 0.25–2.4 mg titration. $125 (6-mo, save $84) · $132 (3-mo, save $21) · $139 (monthly).
Includes: medication, all MD/DO visits, messaging (lab work not stated on its pages), personalized nutrition plan (GLP-1 focused), 1:1 fitness call with certified wellness coach, and medical guidance.
Klarna & Affirm financing accepted at checkout (FAQ).
Compounded only — no brand-name Wegovy® / Ozempic® / Rybelsus®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.
Compounded only — no brand-name Wegovy® / Zepbound®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.
The v3.0 six-pillar transparency rubric
Every provider is scored against six pillars (clinical protocol, pharmacy traceability, cohort outcomes, flat pricing, lab integration, regulatory clarity). Read the full methodology.
Editorial team
Reviewed by Dr. Sam Saberian, medically reviewed by Alen A. Schwartz, MD, edited by Julliana Edwards. About our team →
